ReviewLeukemia & lymphoma2026
Racial disparities in multiple myeloma: biological heterogeneity, treatment access, and prognostic implications.
Review in Leukemia & lymphoma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Regulatory function of ten‑eleven translocation‑2 in transcriptional mechanisms of demethylated myeloma cells.Molecular medicine reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Unlike the well-recognized two-fold higher incidence rate and an earlier age of onset of MM among African Americans (AA) compared to European Americans (EA) in the United States, findings on racial disparities in survival outcomes of MM are inconclusive, ranging from worse survival, to no difference, to better overall survival in AA patients than EA patients. The clinical outcomes for patients with MM depend on a complex interplay of factors including age, disease severity, cytogenetics, treatment modalities, biological features of the responsible clone, and non-biological factors such as treatment utilization and access to care. This review focuses on genetic and molecular heterogeneity of the disease biology and characteristics among MM patients from different populations. The review discusses possible determinants of racial and ethnic disparities in the outcomes of MM and considers potential strategies to address them with an ultimate goal of decreasing MM health disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.